Posts tagged “Biotech & Life Science”
President Obama's BRAIN Initiative - Brain Research through Advancing Innovative Neurotechnologies - second year kickoff includes three RTP connections: Funding from GlaxoSmithKline and research grants for teams at UNC-Chapel Hill as well as Duke.
David Murdock, the 91-year-old billionaire founder of the North Carolina Research Campus, sets aside $15 million annually from his estate with the goal of advancing life science research for years to come. But the feisty Murdock says he still aims to live to 125.
TransEnterix, a developer of robotic and flexible instrument technology for use in surgery, has landed a loan worth up to $25 million. The deal provides "up to three quarters of additional capital to satisfy our operating cash requirements," says CEO.
The billionaire founder of the North Carolina Research Campus will make the gift announcement Tuesday to continue supporting operational expenses and recruit top scientific talent to the state. It's his second large donation by the 91-year-old in the last 16 months.
A team of developers led by Longfellow Real Estate Partners from Boston, Duke University and Durham businessman Hank Scherich will unveil formal plans Wednesday for the "Durham Innovation District." The project is expected to cost hundreds of millions of dollars and cover 1.7 million square feet of office space.
In the latest Bulldog roundup of life science and technology news: Cisco Intercloud partner ecosystem expanded with $1 billion in new financing; Microsoft offers first look at new Windows this week; Anti-Facebook social network Ello goes viral; Yahoo! Directory is shutting down this year; and what can doctors can learn from our Selfies?
Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with more than 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.
WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.
Drug giant GlaxoSmithKline will have a new chairman a year from now: Philip Hampton, the current chair at Royal Bank of Scotland Group. Hampton will first join the GSK board as of Jan. 1 as a director.
New GSK chairman; Lenovo stock pressure; FTC bitcoin crackdown; FAA to OK drones; Cree's new competition
In today's wrapup of life science and technology news: GSK is getting a new chairman in wake of the China bribery scandal, says The Times of London; Lenovo stock faces price pressure; FTC takes aim at bitcoins; FAA to OK drones for Hollywood; Cree's new competition from Philips.
Pharmaceutical maker Novartis on Wednesday celebrated the U.S. Food and Drug Administration's licensing and first shipments of a new flu vaccine that the company says could drastically help with reducing a potential pandemic.
Novartis dedicates $1B vaccine plant with VIP flu shots as NC exec who recruited the firm will watch
It's probably a safe bet that Gov. Pat McCrory has already received his flu shot for the 2014-5 season, but he and other VIPs can line up for vaccinations today as Novartis formally dedicates production at its mammoth $1 billion plant in Holly Springs. But there's also an interesting back story to the event: The N.C. Biotechnology Center exec who helped recruit Novartis to N.C. way back in 2006.
Raleigh-based Salix Pharmaceuticals is talking a possible deal with Allergan, according to multiple media reports. A deal would be worth $10 billion or more as speculation drives up the price of Salix shares to a record high.